Catalyst Capital Advisors LLC Axogen, Inc. Transaction History

Catalyst Capital Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 08, 2018	SELL	$34.05 - $55.9 $755,909 - $1.24 Million	-22,200 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$36.15 - $52.5 $144,600 - $210,000	-4,000 Reduced 15.27%	22,200 $1.12 Million
Q1 2018 May 18, 2018	SELL	$24.4 - $40.25 $222,040 - $366,275	-9,100 Reduced 25.78%	26,200 $956,000
Q4 2017 Feb 08, 2018	BUY	$18.5 - $28.6 $88,800 - $137,280	4,800 Added 15.74%	35,300 $999,000
Q3 2017 Nov 08, 2017	BUY	$14.65 - $19.35 $446,825 - $590,175	30,500	30,500 $590,000

162

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $661M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Catalyst Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Catalyst Capital Advisors LLC with notifications on news.